Cyclic AMP in retina and caudate nucleus: influence of dopamine and other agents
- PMID: 165691
Item in Clipboard
Cyclic AMP in retina and caudate nucleus: influence of dopamine and other agents
Adv Cyclic Nucleotide Res.
1975.
No abstract available
Similar articles
-
Influence of neuroleptic drugs and apomorphine on dopamine-sensitive adenylate cyclase of retina.J Neurochem. 1973 Aug;21(2):477-9. doi: 10.1111/j.1471-4159.1973.tb04268.x. J Neurochem. 1973. PMID: 4353338 No abstract available.
-
Adenosine 3',5'-monophosphate content in rat caudate nucleus: demonstration of dopaminergic and adrenergic receptors.Science. 1974 Dec 20;186(4169):1118-20. doi: 10.1126/science.186.4169.1118. Science. 1974. PMID: 4377761
-
Stimulation by dopamine of adenosine cyclic 3',5'-monophosphate formation in rat caudate nucleus: effect of lesions of the nigro-neostriatal pathway.Mol Pharmacol. 1976 Jul;12(4):639-48. Mol Pharmacol. 1976. PMID: 183096 No abstract available.
-
Dopamine-sensitive adenylate cyclase in the retina: a point of action for D-LSD.Adv Biochem Psychopharmacol. 1976;15:357-65. Adv Biochem Psychopharmacol. 1976. PMID: 799461 Review. No abstract available.
-
The activity of substituted benzamides in biochemical models of dopamine receptors.Adv Biochem Psychopharmacol. 1982;35:17-49. Adv Biochem Psychopharmacol. 1982. PMID: 6293277 Review. No abstract available.
Cited by
-
[3H]-dopamine release from the rabbit retina.Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980;215(2):71-8. doi: 10.1007/BF00414464. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 1980. PMID: 6111260
-
IMI - Report on Experimental Models of Emmetropization and Myopia.Invest Ophthalmol Vis Sci. 2019 Feb 28;60(3):M31-M88. doi: 10.1167/iovs.18-25967. Invest Ophthalmol Vis Sci. 2019. PMID: 30817827 Free PMC article. Review.
-
Retinal dopamine D1 and D2 receptors: characterization by binding or pharmacological studies and physiological functions.Cell Mol Neurobiol. 1990 Sep;10(3):303-25. doi: 10.1007/BF00711177. Cell Mol Neurobiol. 1990. PMID: 2174740 Free PMC article. Review.
-
The role of vasoactive intestinal peptide (VIP) in atropine-related inhibition of the progression of myopia.BMC Ophthalmol. 2024 Jan 26;24(1):41. doi: 10.1186/s12886-024-03309-9. BMC Ophthalmol. 2024. PMID: 38279089 Free PMC article.
-
Vasoactive intestinal peptide, a promising agent for myopia?Int J Ophthalmol. 2017 Feb 18;10(2):211-216. doi: 10.18240/ijo.2017.02.05. eCollection 2017. Int J Ophthalmol. 2017. PMID: 28251078 Free PMC article.